Physician profile
Brandon Patrick Staub
NPI 1063809317
$5,330.74
in general payments reported to CMS, 2019-2025
31 companies · $28.47 in 2025
The $28.47 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,442 · 2020: $606 · 2021: $1,629 · 2022: $1,165 · 2023: $315 · 2024: $146 · 2025: $28.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,685.91 | 2019-2024 | Eterna |
| Abbvie INC. | $768.50 | 2021-2023 | Qulipta, Botox, Ubrelvy |
| Boston Scientific Corporation | $711.50 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Spr Therapeutics, INC | $456.89 | 2020-2024 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $195.17 | 2021-2022 | |
| Medtronic, INC. | $188.61 | 2021-2025 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company LTD. | $180.39 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $162.53 | 2020-2021 | |
| Amgen INC. | $106.86 | 2021-2022 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $73.89 | 2020-2021 | |
| Grt US Holding, INC. | $69.25 | 2021 | |
| Averitas Pharma INC. | $69.20 | 2023-2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $64.44 | 2021 | |
| Allergan, INC. | $49.97 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $49.32 | 2021 | |
| Lundbeck LLC | $46.01 | 2020-2021 | |
| Lilly USA, LLC | $43.53 | 2020-2021 | |
| Medtronic USA, INC. | $42.08 | 2020 | |
| Painteq LLC | $39.40 | 2023-2024 | Painteq |
| Upsher-Smith Laboratories LLC | $35.55 | 2021 | |
| Supernus Pharmaceuticals, INC. | $28.88 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $26.99 | 2022 | |
| Spinal Simplicity, LLC | $26.44 | 2020 | |
| Si-Bone, INC. | $25.41 | 2022 | |
| Ibsa Pharma INC. | $18.40 | 2023 | Tirosint, Licart |
| Conetic Solutions, INC. | $17.78 | 2020 | |
| Impel Pharmaceuticals INC. | $16.49 | 2023 | Trudhesa |
| Zyla Life Sciences, INC. | $14.03 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2022 | |
| Pfizer INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Staub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.